Authors: Schwartz, GK Ilson, D Saltz, L O'Reilly, E Tong, W Maslak, P Werner, J Perkins, P Stoltz, M Kelsen, D

Citation: Gk. Schwartz et al., Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma, J CL ONCOL, 19(7), 2000, pp. 1985-1992

Authors: Fata, F O'Reilly, E Ilson, D Pfister, D Leffel, D Kelsen, DP Schwartz, GK Casper, ES

Citation: F. Fata et al., Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face, CANCER, 86(10), 1999, pp. 2034-2037

Authors: Saltz, LB Spriggs, D Schaaf, LJ Schwartz, GK Ilson, D Kemeny, N Kanowitz, J Steger, C Eng, M Albanese, P Semple, D Hanover, CK Elfring, GL Miller, LL Kelsen, D

Citation: Lb. Saltz et al., Phase I clinical and pharmacologic study of weekly cisplatin combined withweekly irinotecan in patients with advanced solid tumors, J CL ONCOL, 16(12), 1998, pp. 3858-3865